Nikeshan Jeyakumar

8PUBLICATIONS
62CO-AUTHORS
PhysiotherapyAutoimmunityHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 25, 2026
Improved outcomes with TKI maintenance after brexucabtagene autoleucel in Philadelphia chromosome ALL.

|Dec 18, 2025
Clinical and Cytokine Features of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.

Hrishikesh K Srinagesh, Anne Marijn Kramer, John H Baird

|Oct 06, 2025
CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia.

Yannis K Valtis, Chenyu Lin, David Nemirovsky

|May 07, 2025
Outcomes of brexucabtagene autoleucel in patients with relapsed/refractory acute lymphoblastic leukemia with CNS involvement.

Ibrahim N Muhsen, Gregory W Roloff, Rawan Faramand

|Mar 24, 2025
Real-world outcomes for young adult patients receiving CD19 CAR T-cell therapy.

Hannah Lust, Liora M Schultz, Soyang Kwon

|Aug 02, 2024
Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL.

Ibrahim Aldoss, Gregory W Roloff, Rawan Faramand

Pageof 2

Frequent Collaborators

7 joint publications

Lori S Muffly

5 joint publications

Gregory W Roloff

4 joint publications

Bijal D Shah

4 joint publications

Kaitlyn C Dykes